Literature DB >> 6189786

Interaction of viral envelope glycoproteins with fibronectin.

I Julkunen, A Hautanen, J Keski-Oja.   

Abstract

An interaction between fibronectin and viral envelope glycoprotein micelles isolated from influenza A, parainfluenza 1, and mumps viruses was found by enzyme immunoassay. All three different glycoprotein micelles bound efficiently to solid-phase fibronectin. When fibronectin was permitted to bind to solid-phase viral glycoproteins, dose-dependent binding was observed. Soluble glycoprotein micelles inhibited the binding of fibronectin to immobilized glycoprotein preparations. The binding was not observed when fibronectin was pretreated with neuraminidase, suggesting that the sugar moieties of fibronectin are responsible for the affinity. This affinity may play a role in virus-cell interactions or in the opsonization of certain viruses during infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189786      PMCID: PMC348133          DOI: 10.1128/iai.40.3.876-881.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Chemical structure of attachment sites for viruses on human erythrocytes.

Authors:  B J Enegren; A T Burness
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Solid-phase enzyme-immunoassay for detection of hepatitis B surface antigen.

Authors:  G Wolters; L Kuijpers; J Kacaki; A Schuurs
Journal:  J Clin Pathol       Date:  1976-10       Impact factor: 3.411

Review 6.  Fibronectin: current concepts of its structure and functions.

Authors:  E Ruoslahti; E Engvall; E G Hayman
Journal:  Coll Relat Res       Date:  1981

7.  Fibronectin mediates attachment of Staphylococcus aureus to human neutrophils.

Authors:  R A Proctor; E Prendergast; D F Mosher
Journal:  Blood       Date:  1982-04       Impact factor: 22.113

8.  Isolation and purification of the envelope proteins of Newcastle disease virus.

Authors:  A Scheid; P W Choppin
Journal:  J Virol       Date:  1973-02       Impact factor: 5.103

9.  Properties of influenza C virus grown in cell culture.

Authors:  R J O'Callaghan; M Loughlin; D D Labat; C Howe
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

10.  Infectious entry pathway of influenza virus in a canine kidney cell line.

Authors:  K S Matlin; H Reggio; A Helenius; K Simons
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

View more
  17 in total

1.  Plasma fibronectin concentrations in patients with human immunodeficiency virus infection.

Authors:  D Torre; M Issi; C Sampietro; G P Fiori; G Chelazzi; G Ferraro
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

2.  Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells.

Authors:  Pamela Osterlund; Ville Veckman; Jukka Sirén; Kevin M Klucher; John Hiscott; Sampsa Matikainen; Ilkka Julkunen
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections.

Authors:  I Julkunen; T Hovi; I Seppälä; O Mäkelä
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

4.  Interactions of fibronectin with Treponema pallidum.

Authors:  T J Fitzgerald; L A Repesh
Journal:  Genitourin Med       Date:  1985-06

5.  The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens.

Authors:  K Sadeharju; M Knip; M Hiltunen; H K Akerblom; H Hyöty
Journal:  Diabetologia       Date:  2003-07-05       Impact factor: 10.122

6.  Plasma fibronectin concentrations in patients with HIV infection and visceral leishmaniasis.

Authors:  A Rodríguez-Cuartero; J Nuñez-Carrill; A Salas-Galán; M A Rodríguez-Rodríguez
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

7.  Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group.

Authors:  H Hyöty; M Hiltunen; A Reunanen; P Leinikki; T Vesikari; R Lounamaa; J Tuomilehto; H K Akerblom
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

8.  Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.

Authors:  Pamela Osterlund; Jaana Pirhonen; Niina Ikonen; Esa Rönkkö; Mari Strengell; Sanna M Mäkelä; Mia Broman; Ole J Hamming; Rune Hartmann; Thedi Ziegler; Ilkka Julkunen
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

9.  Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders.

Authors:  D Torre; C Zeroli; G Ferrario; G Bonetta; G P Fiori; R Martegani
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

10.  Cerebrospinal fluid concentration of fibronectin in meningitis.

Authors:  D Torre; C Zeroli; M Issi; G P Fiori; G Ferraro; F Speranza
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.